Form 8-K - Current report:
SEC Accession No. 0001104659-25-060704
Filing Date
2025-06-18
Accepted
2025-06-18 17:11:02
Documents
12
Period of Report
2025-06-17
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2518346d1_8k.htm   iXBRL 8-K 36060
  Complete submission text file 0001104659-25-060704.txt   202895

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA sls-20250617.xsd EX-101.SCH 3041
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE sls-20250617_lab.xml EX-101.LAB 34239
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sls-20250617_pre.xml EX-101.PRE 22377
14 EXTRACTED XBRL INSTANCE DOCUMENT tm2518346d1_8k_htm.xml XML 3688
Mailing Address 7 TIMES SQUARE SUITE 2503 NEW YORK NY 10036
Business Address 7 TIMES SQUARE SUITE 2503 NEW YORK NY 10036 6462005278
SELLAS Life Sciences Group, Inc. (Filer) CIK: 0001390478 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33958 | Film No.: 251057779
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)